Persistent Fetal Vasculature: Mechanisms of Development, Current Treatment Approaches, and Advancements in Therapy
-
By
-
Robert H. Henderson
-
October 6, 2026
Objective:
The article reviews persistent fetal vasculature (PFV), covering its developmental biology and clinical classification in the supplied excerpt.
Approach:
- Developmental biology: The article describes hyaloid-vessel formation and regression, including HIF-VEGF signalling, macrophage-derived WNT7b, Norrin/FZD4/LRP5/6 signalling, and genes associated with PFV-like phenotypes.
- Clinical context: The excerpt introduces Goldberg’s anterior, posterior, and combined PFV classification and describes characteristic findings, including retrolental fibrovascular plaque, ciliary-process elongation, a shallow anterior chamber, and posterior stalks, folds, or tractional detachment.
Key Findings:
- PFV is uncommon and is an important cause of infantile leucocoria; it can mimic retinoblastoma.
- The article describes hyaloid regression as an active process involving reduced VEGF signalling and macrophage-mediated endothelial apoptosis.
- Disruption of NDP, FZD4, LRP5, or TSPAN12 can produce PFV-like features and is associated with inherited vitreoretinopathies; biallelic ATOH7 loss-of-function mutations are associated with autosomal-recessive PFV.
- Goldberg’s anterior, posterior, and combined classification links clinical manifestations with the developmental continuum of PFV.
Interpretation:
The article frames PFV as a disorder involving disrupted coordination among angiogenic signalling, vascular regression, and ocular growth, with clinical manifestations spanning anterior and posterior disease.
Limitations:
- The supplied excerpt ends during the clinical classification and multimodal imaging section; it does not include the remainder of the article or its detailed discussion of current treatments and therapeutic advances.
Conclusion:
The supplied excerpt connects PFV’s developmental biology with its clinical classification and characteristic ocular findings; it does not include the article’s later discussion of imaging or treatment.
Based on findings from:
Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics
Robert H. Henderson. Eye, 2026.
https://www.nature.com/articles/s41433-026-04959-3
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.